En Rich Financial Partners LLC Exact Sciences Corp Transaction History
En Rich Financial Partners LLC
- $267 Billion
- Q1 2024
A detailed history of En Rich Financial Partners LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, En Rich Financial Partners LLC holds 908 shares of EXAS stock, worth $39,216. This represents 0.02% of its overall portfolio holdings.
Number of Shares
908Holding current value
$39,216% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
699Shares Held
160MCall Options Held
5.84MPut Options Held
2.58M-
Vanguard Group Inc Valley Forge, PA17.7MShares$766 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA13MShares$563 Million0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY12.4MShares$535 Million0.08% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$491 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$461 Million0.13% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.64B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...